Hebei Changshan Biochemical Pharmaceutical Statistics

Total Valuation

Hebei Changshan Biochemical Pharmaceutical has a market cap or net worth of CNY 17.77 billion. The enterprise value is 19.76 billion.

Market Cap	17.77B
Enterprise Value	19.76B

Important Dates

The next estimated earnings date is Monday, April 28, 2025.

Earnings Date	Apr 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Hebei Changshan Biochemical Pharmaceutical has 919.06 million shares outstanding. The number of shares has decreased by -8.98% in one year.

Current Share Class	n/a
Shares Outstanding	919.06M
Shares Change (YoY)	-8.98%
Shares Change (QoQ)	-67.51%
Owned by Insiders (%)	36.62%
Owned by Institutions (%)	7.19%
Float	559.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.15
PB Ratio	9.77
P/TBV Ratio	11.80
P/FCF Ratio	124.91
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-23.39
EV / Sales	18.73
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	138.82

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 1.32.

Current Ratio	1.13
Quick Ratio	0.31
Debt / Equity	1.32
Debt / EBITDA	n/a
Debt / FCF	16.46
Interest Coverage	-10.73

Financial Efficiency

Return on equity (ROE) is -39.82% and return on invested capital (ROIC) is -12.76%.

Return on Equity (ROE)	-39.82%
Return on Assets (ROA)	-11.64%
Return on Capital (ROIC)	-12.76%
Revenue Per Employee	748,118
Profits Per Employee	-599,000
Employee Count	1,410
Asset Turnover	0.21
Inventory Turnover	0.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +57.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+57.56%
50-Day Moving Average	20.61
200-Day Moving Average	13.34
Relative Strength Index (RSI)	45.29
Average Volume (20 Days)	28,654,415

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hebei Changshan Biochemical Pharmaceutical had revenue of CNY 1.05 billion and -844.59 million in losses. Loss per share was -1.09.

Revenue	1.05B
Gross Profit	-536.35M
Operating Income	-941.69M
Pretax Income	-850.27M
Net Income	-844.59M
EBITDA	-854.46M
EBIT	-941.69M
Loss Per Share	-1.09

Full Income Statement

Balance Sheet

The company has 314.22 million in cash and 2.34 billion in debt, giving a net cash position of -2.03 billion or -2.21 per share.

Cash & Cash Equivalents	314.22M
Total Debt	2.34B
Net Cash	-2.03B
Net Cash Per Share	-2.21
Equity (Book Value)	1.77B
Book Value Per Share	1.98
Working Capital	266.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 307.43 million and capital expenditures -165.13 million, giving a free cash flow of 142.30 million.

Operating Cash Flow	307.43M
Capital Expenditures	-165.13M
Free Cash Flow	142.30M
FCF Per Share	0.15

Full Cash Flow Statement

Margins

Gross margin is -50.85%, with operating and profit margins of -89.27% and -80.07%.

Gross Margin	-50.85%
Operating Margin	-89.27%
Pretax Margin	-80.61%
Profit Margin	-80.07%
EBITDA Margin	-81.00%
EBIT Margin	-89.27%
FCF Margin	13.49%

Dividends & Yields

Hebei Changshan Biochemical Pharmaceutical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	8.98%
Shareholder Yield	8.98%
Earnings Yield	-5.66%
FCF Yield	0.80%

Dividend Details

Stock Splits

The last stock split was on April 20, 2016. It was a forward split with a ratio of 1.8.

Last Split Date	Apr 20, 2016
Split Type	Forward
Split Ratio	1.8

Scores

Hebei Changshan Biochemical Pharmaceutical has an Altman Z-Score of 1.92. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.92
Piotroski F-Score	n/a